Harte Group Expands Global Network to Support Pharmaceutical Companies
Doylestown, Pa.
Harte Group, a global company who manages and represents Functional Service Providers for support of clinical development needs, announced that its growing network of partners has reached 44 companies, employing over 7,900 experienced staff with an average company life of 13 years in business.
Due to a changing landscape within clinical development operations and the market being underserved by the existing full-service CRO model, the Harte Group created a full-service CRO offering - one built by leveraging smaller companies. Many sponsors have been looking for alternatives to support smaller programs in their portfolio, as well as looking for more ways to execute their clinical programs and projects.
"I am excited by the high level of interest in this Functional Services Provider model," said Michael Harte, Founder & President of the Harte Group. Harte mentioned that their team is in active discussions with both large pharma and smaller biotechnology firms.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
